HyBryte™ use in early-stage cutaneous T-cell lymphoma

HyBryte™ use in early-stage cutaneous T-cell lymphoma

Cutaneous T-cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma of the skin, where at later stages skin-homing malignant T-cells affect lymph nodes, blood, and visceral organs. Even though early CTCL does not affect survival, it can progress to more advanced stages of disease and have a sign...

Full description

Bibliographic Details
Main Authors: Brian Poligone, Carolina V. Alexander-Savino, Ellen J. Kim, Aaron R. Mangold, Jennifer Desimone, Henry K. Wong, Adam T. Rumage, Oreola Donini, Andrea Haulenbeek, Christopher J. Schaber, Richard Straube, Christopher Pullion, Alain H. Rook
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Drug Discovery
Subjects:
CTCL
photodynamic therapy
mycosis fungoides
cancer
drug discovery
immunology
Online Access:https://www.frontiersin.org/articles/10.3389/fddsv.2023.1298453/full

Internet

https://www.frontiersin.org/articles/10.3389/fddsv.2023.1298453/full

Similar Items